Hydrate variable cristallin de sel (s)-6-(4-(2-((3-(9h-carbazol-4-yloxy)-2-hydroxypropyl)amino)-2-methylpropyl)phenoxy)-3-pyridinicarbox amide hemisuccinate
2005
L'invention concerne un hydrate variable cristallin de (S)-(3- pyridinecarboxamide,6-[4-[2-[[3-(9H-carbazol-4-yloxy)-2-hydroxypropyl]amino]-2-methylpropyl]phenoxy])-hemi-succinate, une formulation pharmaceutique contenant ledit sel et des procedes pour traiter l'obesite et/ou le diabete de type 2 au moyen desdits sels.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI